Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2428 - A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
4:45 PM - 6:00 PM PT

2429 - Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of a Prospective Trial
Speaker: Mankuzhy, Nikhil, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
4:45 PM - 6:00 PM PT

2430 - Advancing Adaptive Radiotherapy with High-Fidelity CBCT-Based In-Situ Dose Calculation
Speaker: Marasini, Shanti, PhD - Washington University in St. Louis School of Medicine, St Louis, MO
4:45 PM - 6:00 PM PT

2431 - Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Speaker: Marquez, Cesar, MD, PhD - MD Anderson Cancer Center, Houston, TX
4:45 PM - 6:00 PM PT

2432 - Reirradiation for Pediatric Central Nervous System Tumors: Validation of an LQ Model-Based Approach for Critical Structure Dose Constraints and Clinical Outcomes
Speaker: Martynova, Natalia, MD - Dr. Berezin Medical Institute, Saint-Petersburg, Saint-Petersburg
4:45 PM - 6:00 PM PT

2433 - Demographics, Disparities and Clinical Outcomes in Radiation Pneumonitis Hospitalizations with and without Lung Cancer: Retrospective Analysis of National Inpatient Sample (NIS)
Speaker: Mathew, Tijin, MD - Southeast Health, Cape Girardeau, MO
4:45 PM - 6:00 PM PT

2434 - Irradiation-Induced CK2/SUPT16H Axis Modulation Enhances Radiation Resistance in Lung Cancer via DNA Damage Response and Chromatin Remodeling
Speaker: Meng, Rui, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
4:45 PM - 6:00 PM PT

2435 - Targeting Protein Kinase CK2 to Reprogram Phospholipid Metabolism and Enhance the Efficacy of Radioimmunotherapy in Lung Cancer
Speaker: Meng, Rui, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
4:45 PM - 6:00 PM PT

2436 - Impact of Hepatic Radiotherapy on Survival Outcomes in Small Cell Lung Cancer Patients with Liver Metastases: A Retrospective Study
Speaker: Meng, Xiangjiao - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
4:45 PM - 6:00 PM PT

2437 - Prediction of Esophagitis following Intensity-Modulated Radiotherapy for Lung Cancer Using Statistical and Machine Learning Methods
Speaker: Miller, Nathaniel, MD, BS - VCU School of Medicine, Richmond, VA
4:45 PM - 6:00 PM PT

2438 - Outcomes and Toxicity of 60 Gy in 8 Fractions Stereotactic Body Radiotherapy to Peripheral Tumors Adjacent to the Chest Wall: A Single Institution Experience
Speaker: Mobayed, Tala, MD - American University of Beirut Medical Center, Beirut
4:45 PM - 6:00 PM PT

2439 - A Novel Imaging Biomarker for Radiation Induced Cardiotoxicity
Speaker: Modiri, Arezoo, PhD - University of Maryland School of Medicine, Baltimore, Baltimore, MD